Location History:
- St Kilda West, AU (2005)
- St. Kilda, AU (2004 - 2008)
- St. Kilda West, AU (1998 - 2011)
- Melbourne, AU (2017 - 2021)
Company Filing History:
9 out of 80 
3 out of 33 Years Active: 1998-2021
Title: The Innovative Journey of Leonard Charles Harrison
Introduction
Leonard Charles Harrison, an accomplished inventor based in Melbourne, Australia, has made significant contributions to the field of medical research, particularly in the area of autoimmune diseases. With a remarkable portfolio of 12 patents, his work has the potential to advance therapeutic strategies and improve patient outcomes in various health conditions.
Latest Patents
One of Leonard's latest patents focuses on a soluble CD52 glycoprotein and its therapeutic applications. This invention addresses diseases regulated by effector T-cells, such as autoimmune diseases like type 1 diabetes. The patent highlights the development of fusion proteins comprising the soluble glycoprotein, and introduces diagnostic methods reliant on detecting CD52 expression levels in subjects. This innovative approach promises to enhance our understanding and treatment of complex autoimmune disorders.
Career Highlights
Leonard has had an impressive career, contributing his expertise to reputable institutions like the Walter and Eliza Hall Institute of Medical Research and Amrad Corporation Limited. His role in these organizations has been pivotal, fostering advancements in molecular biology and therapeutic innovations.
Collaborations
Throughout his career, Leonard has collaborated with talented individuals, including coworkers Yuxia Zhang and Esther Bandala Sanchez. These partnerships have allowed for the exchange of ideas and have enriched the scope of his research and inventions.
Conclusion
Leonard Charles Harrison exemplifies the spirit of innovation through his dedication to medical research and the development of groundbreaking inventions. His patents not only showcase his creativity but also exemplify the potential to improve treatment options for individuals suffering from autoimmune diseases. With his ongoing contributions and collaborations, the future looks bright for advancements in medical therapies.